AtriCure (ATRC) Research & Development (2010 - 2026)
AtriCure (ATRC) posted quarterly Research & Development of $26.4 million for Q2 2026, down 9.84% year-over-year from $29.3 million in Q2 2025, and up 8.94% quarter-over-quarter from $24.2 million in Q1 2026.
AtriCure (ATRC) Research & Development (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Research & Development for 17 consecutive years, with $26.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development fell 9.84% year-over-year to $26.4 million; the TTM figure through Jun 2026 stood at $98.0 million (down 9.0% YoY), while the FY2025 annual figure was $99.2 million, up 3.15% from the prior year.
- Research & Development grew to $26.4 million in Q2 2026 per ATRC's latest filing, from $24.2 million in the prior quarter.
- Across five years, Research & Development topped out at $35.0 million in Q4 2024 and bottomed at $13.6 million in Q1 2022.
- Historically, Research & Development has averaged $21.0 million across 5 years, with a median of $20.6 million in 2023.
- Annual changes were most pronounced in 2024 — Research & Development jumped 68.09% — and 2025, when it fell 29.9%.
- AtriCure's Research & Development stood at $13.7 million in 2022, then surged by 51.27% to $20.8 million in 2023, then surged by 68.09% to $35.0 million in 2024, then fell by 29.9% to $24.5 million in 2025, then rose by 7.74% to $26.4 million in 2026.
- Business Quant data shows ATRC's Research & Development at $26.4 million in Q2 2026, $24.2 million in Q1 2026, and $24.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | AtriCure | 2.32 Bn | 2.15 Bn | 118.63 Mn | 26.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.40 Mn |
| Mar 31, 2026 | 24.24 Mn |
| Dec 31, 2025 | 24.51 Mn |
| Sep 30, 2025 | 22.89 Mn |
| Jun 30, 2025 | 29.28 Mn |
| Mar 31, 2025 | 22.53 Mn |
| Dec 31, 2024 | 34.96 Mn |
| Sep 30, 2024 | 20.96 Mn |
| Jun 30, 2024 | 20.42 Mn |
| Mar 31, 2024 | 19.85 Mn |
| Dec 31, 2023 | 20.80 Mn |
| Sep 30, 2023 | 20.35 Mn |
| Jun 30, 2023 | 17.44 Mn |
| Mar 31, 2023 | 15.33 Mn |
| Dec 31, 2022 | 13.75 Mn |
| Sep 30, 2022 | 15.17 Mn |
| Jun 30, 2022 | 14.79 Mn |
| Mar 31, 2022 | 13.63 Mn |
| Dec 31, 2021 | 13.81 Mn |
| Sep 30, 2021 | 11.28 Mn |